ArticleBiomedicines2024

Triple Combinations of Histone Lysine Demethylase Inhibitors with PARP1 Inhibitor-Olaparib and Cisplatin Lead to Enhanced Cytotoxic Effects in Head and Neck Cancer Cells.

Dawid Dorna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.